	A novel model for predicting prognosis in pancreatic cancer patients: a retrospective study. Front Oncol Jiang M, Zhou M. PMID: 41522235 [PubMed]
	Checking Up on the King of Cancers. Cancer Discov Tsui WHA, Lo YMD. PMID: 41521773 [PubMed - indexed for MEDLINE]
	Effect of Direct-Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan. Hepatol Res Ochi H, Kurosaki M, Tanaka T, Akahane T, Marusawa H, Kobashi H, Fujii H, Morita A, Uchida Y, Okada K, Urawa N, Mori N, Tsuji K, Okamoto E, Ogawa C, Kondo M, Nonogi M, Uchino K, Yoshida H, Izumi N. PMID: 41521590 [PubMed - as supplied by publisher]
	Precision oncology promise in the management of pancreatic acinar cell carcinoma. Eur J Cancer Baskar S, Patel RR, Gao MT, Rose BE, Bawek S, Vadehra D, Brown TJ, Hornstein NJ, Grewal US. PMID: 41518684 [PubMed - as supplied by publisher]
	Diagnosis and Surgical Management for Advanced Pancreatic Cancer Requiring Vascular Resection. Diagnostics (Basel) Solonas S, Evangelos LD, Georgios GK. PMID: 41515597 [PubMed]
	Advances in Neoantigen-Based Cancer Vaccines. Cancers (Basel) Wu AC, Nakamura Y, Kiyotani K. PMID: 41514653 [PubMed]
	Clear Cell Renal Cell Carcinoma Metastasis to the Thyroid: A Narrative Review of the Literature. Cancers (Basel) Samaras MG, Pouliakis A, Skaretzos K, Boutas I, Kontogeorgi A, Dimas DT, Ieronimaki AI, Zanelli M, Palicelli A, Zizzo M, Broggi G, Caltabiano R, Salzano S, Koufopoulos NI. PMID: 41514570 [PubMed]
	Depression as a Prodromal Symptom of Pancreatic Cancer: A Narrative Review. Cancers (Basel) Deori C, Andreis F, Giubileo V, Noventa S, Oneda E, Meriggi F, Zaniboni A. PMID: 41514529 [PubMed]
	RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer. Anal Chim Acta Lásko Z, Peterka O, Jirásko R, Taylor A, Hájek T, Mohelníková-Ducho, Love, Melichar B, Hol. PMID: 41513367 [PubMed - indexed for MEDLINE]
	Real world deployment of a pancreatic cancer risk model: impact of refitting, imputation, and computational burden. EBioMedicine Chen W, Zhou B, Luong TQ, Xie F, Wu BU. PMID: 41512677 [PubMed - as supplied by publisher]
	Impact of nutritional status on chemotherapy delivery and outcomes in advanced pancreatic cancer: A prospective multicenter study. Clin Nutr Kiriukova M, Orsi G, Sandru V, de la Iglesia D, Panic N, Bozhychko M, Avci B, Burini A, Cardellini S, Loliva V, Archibugi L, Macchini M, Panaitescu-Damian A, Bordin D, Arcidiacono PG, Maisonneuve P, de-Madaria E, Reni M, Capurso G. PMID: 41512634 [PubMed - as supplied by publisher]
	Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer. JCO Clin Cancer Inform Ahmed KS, Marcinak CT, Ali MM, Issaka SM, Yan Y, McMahan G, Callaci T, LoConte NK, Shiefelbein A, Weber S, Afshar M, Churpek MM, Mathew J, Zafar SN. PMID: 41512230 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Atezolizumab Plus Bevacizumab Versus Durvalumab Plus Tremelimumab for Unresectable Hepatocellular Carcinoma in Patients With Child-Pugh Class B: A Real-World Study. Hepatol Res Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishimura T, Tsuji K, Ishikawa T, Tajiri K, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Kuroda H, Yata Y, Nishikawa H, Tanaka H, Imai M, Aoki T, Ochi H, Tamai H, Komatsu S, Ueda Y, Kim SK, Tada F, Nakamura S, Matsuura T, Nakamura Y, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Tanaka K, Koshiyama Y, Kanayama Y, Noritake H, Okamura J, Enomoto H, Matsui K, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Kumada T, RELPEC Group and HCC 48 Group. PMID: 41511823 [PubMed - as supplied by publisher]
	Pilot Randomized Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Newly Diagnosed Advanced Pancreatic Cancer (CanPan). JCO Oncol Pract Zylla D, Chrenka E, Lin K, Gilmore G, Cowger J, Rak D, Gupta A. PMID: 41510814 [PubMed - as supplied by publisher]
	High-Grade Pancreatic Neuroendocrine Carcinoma Presenting as Dorsal Spinal Cord Compression: A Diagnostic and Surgical Challenge for the Orthopedic Oncologist. J Orthop Case Rep Choudhary R, Negi R, Bahagotia UK, Dwajan A. PMID: 41509745 [PubMed]
	Beta-Blocker Use and Survival Outcomes in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. Clin Med Insights Oncol Li R, Chen J, Chen Y, Jin K, Chen Y, Deng C, Liu X, Li Y. PMID: 41509003 [PubMed]
	Uncovering the potential of pathomics: prognostic prediction and mechanistic investigation of pancreatic cancer. J Pathol Liu L, Zhao X, Zhang F, Huang Y, Wang Q, Fang Z, Zhu Y, Zhang Y. PMID: 41508286 [PubMed - as supplied by publisher]
	Esophageal neuroendocrine carcinoma: molecular insights, diagnostic advances, and emerging treatment strategies. Clin Transl Oncol Wu XW, Du Y, Jiao Y. PMID: 41507459 [PubMed - as supplied by publisher]
	Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis. Ann Surg Oncol Procopio F, Memeo R, Del Fabbro D, Abdelhadi S, Reissfelder C, Edwin B, Milana F, Troisi RI, Torzilli G, Minimally Invasive R1 Vascular Group. PMID: 41507450 [PubMed - as supplied by publisher]
	Obesity and Cancer: Mechanisms, Epidemiological Evidence, and Potential Risk Reduction. J Obes Metab Syndr Lim JS, Kim S, Cho IY, Shin DW. PMID: 41506747 [PubMed - as supplied by publisher]

Articles 1 - 20 / 58753

Page 1 of 2938



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy